Meridian Bioscience
VIVO
$33.97
Share price
0.00%
Change (1 day)
24.02%
Change (1 year)
Categories
EPS for Meridian Bioscience (VIVO)
EPS in 2022 (TTM): $0.97
According to Meridian Bioscience's latest financial reports the company's current EPS (TTM) is $0.97. In 2021 the company made an earnings per share (EPS) of $1.38 a decrease over its 2020 EPS that were of $1.63.
EPS history for Meridian Bioscience from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | $0.97 | -29.71% |
| 2021 | $1.38 | -15.34% |
| 2020 | $1.63 | 254.35% |
| 2019 | $0.46 | -23.33% |
| 2018 | $0.60 | 15.38% |
| 2017 | $0.52 | -26.76% |
| 2016 | $0.71 | -18.39% |
| 2015 | $0.87 | 2.35% |
| 2014 | $0.85 | -5.56% |
| 2013 | $0.90 | 4.65% |
| 2012 | $0.86 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $15.34 | 1,481.44% | 🇺🇸 USA |
 Becton Dickinson BDX | $5.55 | 472.16% | 🇺🇸 USA |
 Hologic HOLX | $1.95 | 101.03% | 🇺🇸 USA |
 QuidelOrtho QDEL | $0.20 | -79.38% | 🇺🇸 USA |